| AIF | apoptosis-inducing factor |
| APAF1 | apoptotic protease-activating factor 1 |
| APC | antigen-presenting cell |
| ASC | adapter protein apoptosis-associated speck-like protein containing a CARD |
| ASCO | apoptosis-associated speck-like protein containing a caspase recruitment domain |
| ATM | ataxia telangiectasia mutated (A-T mutated) |
| ATR | ataxia telangiectasia and Rad3-related |
| ATRIP | ATR-interacting protein |
| BCL-2 | apoptosis regulator BCL2 |
| BCL-xL | B-cell lymphoma-extra large |
| CDC25A/C | M-phase inducer phosphatases |
| CDK | cyclin-dependent kinase |
| CHK1/2 | checkpoint kinases |
| CL | Cardiolipin |
| CRT | Calreticulin |
| CXCL | C-X-C motif chemokine receptors |
| DAMPs | damage-associated molecular patterns |
| DDR | DNA damage response |
| DFNA5 | deafness, autosomal dominant 5, isoform CRA |
| DIABLO | direct inhibitor of apoptosis-binding protein with low |
| DNA-PKcs | DNA-dependent protein kinase catalytic subunit |
| DOX | Doxorubicin |
| DPC | DNA–protein crosslink |
| DR5 | death receptor 5 |
| DSBs | double-strand breaks |
| eEF-2K | eukaryotic elongation factor-2 kinase |
| EMT | epithelial–mesenchymal transition |
| ER | Endoplasmic reticulum |
| ETAA1 | Ewing’s tumor-associated antigen 1 |
| ETC | electron transport chain |
| FASL | FAS antigen ligand |
| FDA | Food and Drug Administration |
| FLIP | FLICE/caspase-8 inhibitory protein |
| GATA4 | GATA Binding Protein 4 |
| GPX4 | glutathione peroxidase |
| GSDMD/E | gasdermin-D/E |
| GZMA/B | granzyme A/B |
| HMGB1 | high mobility group box protein B1 |
| HR | homologous recombination |
| IFNs | Interferons |
| ILs | Interleukins |
| IREs | iron-response elements |
| IRF1 | interferon regulatory factor 1 |
| IRP1/2 | iron regulatory proteins 1/2 |
| JAK | tyrosine-protein kinase JAK |
| JNK | C-Jun N-terminal kinase |
| MAVS | adaptor protein mitochondrial antiviral signaling |
| MCM2/7 | minichromosome maintenance helicase complex |
| MDA-5 | melanoma differentiation Ag-5 |
| MDC-1 | mediator of DNA damage checkpoint protein 1 |
| MDR1 | multidrug resistance 1 |
| MHC | major histocompatibility complex |
| MRE11 | meiotic recombination 11 homolog 1 |
| MRN | MRE11–RAD50–NBS1 complex |
| mtDNA | mitochondrial DNA |
| NBS1 | Nibrin |
| nDNA | nuclear DNA |
| NFAT | nuclear factor of activated T-lymphocytes |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NHEJ | non-homologous end joining |
| NK | natural killer cell |
| NLRP3 | NACHT, LRR, and PYD domains-containing protein 3 |
| NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
| NRF2 | nuclear factor erythroid 2-related factor 2 |
| P2RX7 | P2X purinoceptor |
| PARP-1 | poly(ADP-ribose) polymerase 1 |
| PARs | poly(ADP-ribose) polymers |
| PD-L1 | programmed death ligand 1 |
| PEG | polyethylene glycol |
| PFNs | Perforins |
| PG-P | P-glycoprotein |
| PIKKs | phosphoinositide 3-kinase-related protein kinases |
| PNKP | polynucleotide kinase phosphatase |
| pRB | retinoblastoma protein |
| PRDX2 | peroxiredoxin-2 |
| PUMA | isoform 1 of Bcl-2-binding component 3, isoforms 1/2 |
| RHINO | RAD9, RAD1, HUS1 interacting nuclear orphan |
| RIG-1 | retinoic acid inducible gene-I |
| RNS | reactive nitrogen species |
| ROS | reactive oxygen species |
| RPA | replication protein A |
| SASP | senescence-associated secretory phenotype |
| SOD2 | superoxide dismutase 2 |
| SMAC | secondary mitochondria-derived activator of caspases |
| SSBR | single-strand break repair |
| SSBs | single-strand breaks |
| ssDNA | single-stranded DNA |
| STAT1/2/3 | signal transducer and activator of transcription 1/2/3 |
| TAMs | tumor-associated macrophages |
| TPD-1 | tyrosyl-DNA phosphodiesterase 1 |
| TIS | therapy-induced senescence |
| TLR4 | Toll-like receptor 4 |
| TNFR1 | tumor necrosis factor receptor 1 |
| TNF-α | tumor necrosis factor α |
| TOPB1 | topoisomerase 2-binding protein 1 |
| TP53 | cellular tumor antigen p53 |
| TRAIL | TNF-related apoptosis inducing ligand |
| TRX1 | thioredoxin-1 |
| XRCC1 | X-ray repair cross-complementing group-1 |